Navigation Links
A roadmap for calibration and validation
Date:10/22/2007

The volume of data acquired by more than 50 Earth Observation satellites is increasing at an exponential rate and is providing unprecedented synoptic views of our planet. Because these satellites often use different methodologies, using data for trend analysis and environmental monitoring can be difficult, making it essential to establish globally recognised guidelines for Calibration and Validation processes.

More than 50 experts from space agencies and organisations around the world met earlier this month at the GEO/CEOS Workshop on Calibration and Validation Processes in Geneva, Switzerland, to identify and scope key elements needed to develop and implement a data quality strategy.

Calibration is the process of quantitatively defining the system responses to known, controlled signal inputs. Validation is the process of assessing, by independent means, the quality of the data products derived from the system outputs.

The workshop, hosted by the Group on Earth Observations (GEO) and ESA from 2 to 4 October, was structured around four main sessions:

  • Cal/Val site characterisation & classification

  • Satellite and in situ Cal/Val data access

  • Methodology and guidelines for Cal/Val

  • Harmonisation of quality information

At the beginning of each session, the chair presented a summary of the relevant key issues and then opened the floor for discussion.

The dialogue and recommendations will be used to achieve the ultimate goal of the Global Earth Observation System of Systems (GEOSS) for data inter-operability and inter-comparison. Prof. Jose Achache, Director, GEO Secretariat, stressed that in order for GEOSS to be fully successful, there must be calibration, validation and intercalibration between all instruments.

The Committee on Earth Observation Satellites (CEOS), the space contribution to GEOSS, identified the need to take a more a
'/>"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-069-418-0856
European Space Agency
Source:Eurekalert

Page: 1 2

Related biology news :

1. DOE publishes research roadmap for developing cleaner fuels
2. Genetic roadmap charts links between drugs and human disease
3. UCSD researchers create roadmap to integrin activation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ased to announce the publication of results from i...acy and tolerability of its novel, intranasal drug...ic rhinosinusitis with nasal polyps in Rhinology ...ropean Rhinologic Societies. , Chronic rhinosin... can significantly reduce a patient,s quality of l...
(Date:12/1/2009)...sity cancer researchers have developed a tumor-at...d blocks the growth of new tumor blood vessels. ,...ll cancer cells oncolytic viruses might be more ...also carry a gene for a protein that inhibits bloo...tin, is normally produced in the brain. In this st...
(Date:12/1/2009)...tacks by sharks can be solved with a new technique...they put on their victims, according to a Universi...a method analogous to analyzing human fingerprints... comparing shark bites to the jaws and teeth of th...r of the International Shark Attack File, which is...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Tumor-attacking virus strikes with 'one-two punch' 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 1Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 2Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 1Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 2Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 3Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 4If 2 Painkillers Are Banned What Next 3F 50662 1If 2 Painkillers Are Banned What Next 3F 50662 2If 2 Painkillers Are Banned What Next 3F 50662 3If 2 Painkillers Are Banned What Next 3F 50662 4
...entists working in an ice-free region of Antarctic...e form of fossilized plants and insects--on the in...atures began a relentless drop millions of years a... degrees Celsius, over a relatively brief period o...rced the extinction of tundra plants and insects a...
... traditionally focused on protecting individual sp...ring, however, that preserving the benefits that w...ally and environmentally valuable. At the Annual M... ecologists will explore the application of ecosys...tem services are the benefits that humans reap fro...
... professor and Georgia Research Alliance Eminent S...eorgia, has been awarded $9.2 million as part of a...e of General Medical Sciences, part of the Nationa...rtered in the department of biochemistry and molec...ings of the early steps that stem cells take in be...
Other Biology News:Antarctic fossils paint a picture of a much warmer continent 2Antarctic fossils paint a picture of a much warmer continent 3Antarctic fossils paint a picture of a much warmer continent 4Antarctic fossils paint a picture of a much warmer continent 5Evaluating ecosystem services 2Evaluating ecosystem services 3UGA researchers win $9.2 million stem cell grant from NIH 2
(Date:12/2/2009)...swire/ -- S*BIO Pte Ltd today announced data prese... at The American Society of Hematology 51st Annual... will be presented on the clinical results from th...g its safety, tolerability and pharmacokinetic/pha...g from 100 to 600 mg. These doses were administere...
(Date:12/2/2009).../PRNewswire-Asia/ -- Simcere Pharmaceutical Group,...ding pharmaceutical company,specializing in the de...,generic and proprietary pharmaceuticals in China,...ncluded in China,s National Drug Reimbursement Lis...f Human Resources and Social,Security on November ...
(Date:12/2/2009)...swire-Asia/ -- The world is going through,extraord...y is part of many,businesses and industries. It tu...ly immune to the economic downturn, because illnes...idst of the difficult times this year, the pharmac... R&D center in Shanghai, the largest of,its ki...
(Date:12/2/2009)...wire/ -- According to the National Institute of He...sed with diabetes already have some stage of diabe...the retina caused by leaky blood vessels, is a maj...is one of the most feared diabetic complications. ...had diabetes for 10 years or more will experience ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...t. 8 Wyeth Pharmaceuticals, a,division of Wyeth (...ts have,begun for XYNTHA(TM) Antihemophilic Factor...ant factor VIII product for both the,control and p...laxis in,patients with hemophilia A, a rare, inher... using state-of-the-art manufacturing and,purifica...
...wswire-FirstCall/ - Oncolytics Biotech Inc.,("Onco...at that it has,started patient enrolment in a Phas...n of REOLYSIN(R) in combination with paclitaxel an...eck cancers. The Principal,Investigator is Dr. Mon...CTRC) at The University of Texas Health Science Ce...
...rescriber, Software Simplifies Medicare - For Free...,announced the latest release of their PlanPrescri...o longer need to worry about whether they are,gett...ns. PlanPrescriber,the brainchild of MIT Professor... advice to help seniors quickly find their best Me...
Other Biology Technology:New Recombinant XYNTHA Now Available for Patients with Hemophilia A 2New Recombinant XYNTHA Now Available for Patients with Hemophilia A 3New Recombinant XYNTHA Now Available for Patients with Hemophilia A 4New Recombinant XYNTHA Now Available for Patients with Hemophilia A 5Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 3On-Line Medicare Advisor Saves Seniors Time, Hassle and Money 2
Goat Anti-Human EML1 (K-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
BCASMC (B350-05) from European Collection of Cell Cultures (ECACC)
BAOSMC (B354-05) from European Collection of Cell Cultures (ECACC)
Adaptor for ABI 3700 (AB-0800) from ABgene
Biology Products: